Centessa
emerging safety data and ability to reduce bleeding | Centessa
Company
Deck Type
IPO
Sector
Industry
Deck date
May 2021
Slide
20 of 33
Related slides by other companies
Kymera
Investor Day
December 2021
summary of phase sad mad | Kymera
BenevolentAI
Investor Conference
January 2024
ben phase a study overview | BenevolentAI
BAT
Results
July 2020
quantum the benefits of phase at | BAT
BenevolentAI
Investor Presentation
October 2022
ben phase safety and tolerability study successfully completed phase double blind placebo controlled in patient two part clinical study phase first in human dose phase completed mild moderate patients years per cohort ben placebo safety tolerability adaptive multiple ascending dose cohort design includes imaging to evaluate human skin phase successfully completed safety and tolerability arm adaptive design for phase of the clinical study | BenevolentAI
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io